Patents Assigned to Cambridge Theranostics Ltd.
  • Methods relating to treatment of atherosclerosis
    Patent number: 7504226
    Abstract: The present invention relates to the identification of lipid oxidising antibodies as a key pathogenic factor in atherosclerotic disorders. These disorders may be treated by inhibiting this antibody mediated lipid oxidation and methods and means for identifying and producing inhibitory agents are provided.
    Type: Grant
    Filed: August 22, 2002
    Date of Patent: March 17, 2009
    Assignee: Cambridge Theranostics Ltd.
    Inventor: Ivan Petyaev
  • Treatment of atherosclerotic disorders
    Patent number: 7419657
    Abstract: The present invention relates to the identification of lipid oxidizing abzymes as a key pathogenic factor in atherosclerotic disorders. Methods and means for the reduction of abzyme mediated lipid oxidation in the vascular system are provided as therapeutic approaches for the treatment of atherosclerotic disorders. Methods are provide for determining the efficacy of treatment.
    Type: Grant
    Filed: August 22, 2002
    Date of Patent: September 2, 2008
    Assignee: Cambridge Theranostics Ltd.
    Inventor: Ivan Petyaev
  • Methods and means relating to atherosclerosis
    Patent number: 7148028
    Abstract: The present invention relates to the identification of lipid oxidising antibodies as a key pathogenic factor in atherosclerotic disorders. The presence of such antibodies is a important marker for the diagnosis and prognosis of such disorders and methods and means for the assessment of athersclerotic conditions are provided herein.
    Type: Grant
    Filed: August 22, 2002
    Date of Patent: December 12, 2006
    Assignee: Cambridge Theranostics Ltd.
    Inventor: Ivan Petyaev